We are live on ! Find out more
SRTS icon

Sensus Healthcare

65 hedge funds and large institutions have $33.9M invested in Sensus Healthcare in 2024 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,600% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 1

1,068% more call options, than puts

Call options by funds: $222K | Put options by funds: $19K

145% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 11

50% more capital invested

Capital invested by funds: $22.6M → $33.9M (+$11.3M)

30% more funds holding

Funds holding: 5065 (+15)

6.21% more ownership

Funds ownership: 23.71%29.92% (+6.2%)

Holders
65
Holders Change
+15
Holders Change %
+30%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
27
Reduced
11
Closed
1
Calls
$222K
Puts
$19K
Net Calls
+$203K
Net Calls Change
+$46K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$5.12M -$286K -39,030 -5%
Renaissance Technologies
2
Renaissance Technologies
New York
$2.98M +$158K +21,600 +5%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$2.62M +$652K +88,953 +31%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$2.41M +$323K +44,052 +14%
Morgan Stanley
5
Morgan Stanley
New York
$1.73M +$469K +64,038 +35%
Citadel Advisors
6
Citadel Advisors
Florida
$1.36M +$886K +120,909 +158%
Arrowstreet Capital
7
Arrowstreet Capital
Massachusetts
$1.04M +$493K +67,269 +81%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$1.02M +$2.98K +406 +0.3%
UBS Group
9
UBS Group
Switzerland
$950K +$549K +74,937 +120%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$946K +$2.99K +408 +0.3%
Marshall Wace
11
Marshall Wace
United Kingdom
$915K +$484K +65,994 +100%
PCM
12
Perritt Capital Management
Illinois
$869K
S
13
Sachetta
Massachusetts
$830K -$6.68K -912 -0.8%
Goldman Sachs
14
Goldman Sachs
New York
$693K +$631K +86,126 +613%
OSAM
15
O'Shaughnessy Asset Management
Connecticut
$645K +$270K +36,785 +65%
EI
16
EAM Investors
California
$637K -$36.4K -4,964 -5%
Two Sigma Investments
17
Two Sigma Investments
New York
$626K -$465K -63,521 -41%
Northern Trust
18
Northern Trust
Illinois
$614K +$261K +35,676 +67%
Squarepoint
19
Squarepoint
New York
$593K +$400K +54,576 +175%
Millennium Management
20
Millennium Management
New York
$590K +$450K +61,403 +257%
BlackRock
21
BlackRock
New York
$557K +$104K +14,191 +21%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$443K +$203K +27,702 +76%
State Street
23
State Street
Massachusetts
$414K +$19.8K +2,700 +5%
Man Group
24
Man Group
United Kingdom
$411K +$110K +15,059 +34%
OAC
25
OMERS Administration Corp
Ontario, Canada
$381K +$404K +55,100 New

SRTS Hedge Fund Activity: Q4 2024 in Review

65 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q4 2024, worth a combined $33.9M — up 50% from $22.6M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new SRTS positions and 1 closed out — a net gain of 16 holders — while 27 added to existing stakes and 11 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $886K. The largest seller was Two Sigma Advisers, cutting an estimated $548K.

  • 65 institutional investors held Sensus Healthcare (SRTS) as of Q4 2024, up from 50 in Q3 2024.
  • Funds reported $33.9M of Sensus Healthcare stock for Q4 2024, up 50% quarter-over-quarter.
  • 17 funds opened new Sensus Healthcare positions in Q4 2024 and 1 closed out, a net change of +16 holders.
  • The largest Sensus Healthcare buyer in Q4 2024 was Citadel Advisors, an estimated $886K added.
  • The largest Sensus Healthcare seller in Q4 2024 was Two Sigma Advisers, an estimated $548K sold.

Based on aggregated 13F filings for Q4 2024.